Literature DB >> 8562042

Collagen types in the middle ear mucosa.

A G Nerlich1.   

Abstract

The distribution of various collagen types--in particular that of type II as the major collagen in cartilage--in normal auricular structures is discussed with reference to a 1994 report by Ovesen describing the presence of collagen type II in normal middle ear mucosa. In contrast to this report, no collagen type II is normally found in the normal mucosa of the middle ear, while multiple structures of the normal middle and inner ear (which mostly consist of cartilage or have at least a cartilaginous origin) contain this unique collagen type. This indicates that the collagen type II staining previously observed in the normal middle ear mucosa is most likely an artifact. Of the at least 18 collagen types now known, interstitial and ubiquitously present types I, III and V can be found in the normal middle ear. The minor cartilage collagen types IX and XI have been found in cartilage of the middle (and inner) ear. The basement membrane collagen type IV is normally present in different microanatomical settings, particularly in the epithelial and endothelial basement membranes. In general, an exclusive morphometric estimation of area changes for collagens, particularly for collagen type IV, regardless of any tissue localization seems to be of minor value, since no attribution can be drawn to any of the histoanatomical structures present in the ear. The presence of further collagen types has not yet been tested in normal auricular structures.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8562042     DOI: 10.1007/bf00167317

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  22 in total

1.  The immunohistochemical distribution of collagens type IV, V, VI and of laminin in the human oral mucosa.

Authors:  J Becker; D Schuppan; E G Hahn; G Albert; P Reichart
Journal:  Arch Oral Biol       Date:  1986       Impact factor: 2.633

Review 2.  Localization of collagen types in tissues.

Authors:  K von der Mark
Journal:  Int Rev Connect Tissue Res       Date:  1981

3.  Immunochemistry, genuine size and tissue localization of collagen VI.

Authors:  H von der Mark; M Aumailley; G Wick; R Fleischmajer; R Timpl
Journal:  Eur J Biochem       Date:  1984-08-01

4.  Antibodies to distinct types of collagens and procollagens and their application in immunohistology.

Authors:  R Timpl; G Wick; S Gay
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

5.  Monoclonal antibodies against bovine type IX collagen (LMW fragment): production, characterization, and use for immunohistochemical localization studies.

Authors:  X J Ye; K Terato; H Nakatani; M A Cremer; T J Yoo
Journal:  J Histochem Cytochem       Date:  1991-03       Impact factor: 2.479

6.  Immunohistochemical quantitation of collagen types I, II, IV and V in the ventilated and non-ventilated rabbit middle ear with otitis media with effusion.

Authors:  T Ovesen; P Paaske; T Ledet; O Elbrönd
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

7.  [Immunohistochemical basement membrane analysis of cholesteatoma epithelium].

Authors:  S Lang; A Nerlich; I Wiest; M Schreiner
Journal:  Laryngorhinootologie       Date:  1994-07       Impact factor: 1.057

8.  Localization of type II, IX and V collagen in the inner ear.

Authors:  N B Slepecky; J E Savage; T J Yoo
Journal:  Acta Otolaryngol       Date:  1992       Impact factor: 1.494

9.  Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical Study.

Authors:  S Ergün; X Zheng; B Carlsöö
Journal:  Acta Otolaryngol       Date:  1994-05       Impact factor: 1.494

10.  Expression of the mouse alpha 1(II) collagen gene is not restricted to cartilage during development.

Authors:  K S Cheah; E T Lau; P K Au; P P Tam
Journal:  Development       Date:  1991-04       Impact factor: 6.868

View more
  1 in total

Review 1.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.